Baudax Bio to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

Rhea-AI Summary

MALVERN, Pa., Nov. 15, 2021 - Baudax Bio, a pharmaceutical company focused on developing innovative acute care products, announced that its CEO Gerri Henwood will participate in a fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference from November 29 to December 2, 2021. The chat will be available for on-demand listening starting November 22, 2021, at 10:00 a.m. ET on the company's website. Baudax Bio's lead product, ANJESO, is the first 24-hour intravenous COX-2 preferential NSAID for managing moderate to severe pain.

MALVERN, Pa., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX) a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, today announced Gerri Henwood, the Company’s President and Chief Executive Officer, will participate in a fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference being held November 29 – December 2, 2021.

The fireside chat will be made available for on-demand listening beginning Monday, November 22, 2021 at 10:00 a.m. Eastern Time and may be accessed on the “Events” page within the investors section of the Baudax Bio website at https://www.baudaxbio.com/news-and-investors. A replay will be available on the Baudax Bio website for a period of 30 days following the event.

About Baudax Bio

Baudax Bio is a pharmaceutical company focused on commercializing and developing innovative products for acute care settings. ANJESO is the first and only 24-hour, intravenous (IV) COX-2 preferential non-steroidal anti-inflammatory (NSAID) for the management of moderate to severe pain. In addition to ANJESO, Baudax Bio has a pipeline of other innovative pharmaceutical assets including two novel neuromuscular blocking agents (NMBAs) and a proprietary chemical reversal agent specific to these NMBAs. For more information, please visit www.baudaxbio.com.

CONTACT:

Investor Relations Contact:

Argot Partners
Sam Martin / Claudia Styslinger
(212) 600-1902
baudaxbio@argotpartners.com

Media Contact:

Argot Partners
David Rosen
(212) 600-1902
david.rosen@argotpartners.com

FAQ

When will Baudax Bio's fireside chat take place?

The fireside chat will occur during the Piper Sandler 33rd Annual Virtual Healthcare Conference from November 29 to December 2, 2021.

How can I access the fireside chat by Baudax Bio?

The fireside chat will be available for on-demand listening starting November 22, 2021, at 10:00 a.m. ET on the Baudax Bio website.

What is ANJESO by Baudax Bio?

ANJESO is the first and only 24-hour intravenous COX-2 preferential NSAID for managing moderate to severe pain.

What other products does Baudax Bio have in its pipeline?

Baudax Bio has a pipeline that includes two novel neuromuscular blocking agents and a proprietary chemical reversal agent.

What is the stock symbol for Baudax Bio?

The stock symbol for Baudax Bio is BXRX.